Gi Hong Choi

7.8k total citations
218 papers, 3.9k citations indexed

About

Gi Hong Choi is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Gi Hong Choi has authored 218 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Hepatology, 119 papers in Surgery and 59 papers in Epidemiology. Recurrent topics in Gi Hong Choi's work include Hepatocellular Carcinoma Treatment and Prognosis (111 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (75 papers) and Liver Disease Diagnosis and Treatment (52 papers). Gi Hong Choi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (111 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (75 papers) and Liver Disease Diagnosis and Treatment (52 papers). Gi Hong Choi collaborates with scholars based in South Korea, United States and Japan. Gi Hong Choi's co-authors include Jin Sub Choi, Kyung Sik Kim, Dai Hoon Han, Young Nyun Park, Woo Jung Lee, Chang Moo Kang, Kwang‐Hyub Han, Jin Sub Choi, Jun Yong Park and Jeong Eun Yoo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Gi Hong Choi

190 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gi Hong Choi South Korea 38 2.3k 1.9k 1.1k 1.0k 928 218 3.9k
Jin Sub Choi South Korea 35 2.4k 1.0× 1.9k 1.0× 1.4k 1.3× 1.4k 1.3× 860 0.9× 169 4.0k
Parissa Tabrizian United States 28 1.9k 0.8× 1.4k 0.7× 697 0.6× 984 1.0× 582 0.6× 107 3.3k
Albert Chan Hong Kong 40 3.6k 1.6× 2.2k 1.2× 1.3k 1.1× 2.1k 2.1× 913 1.0× 239 5.3k
Mina Komuta Belgium 33 1.7k 0.8× 2.6k 1.4× 1.5k 1.3× 1.3k 1.3× 830 0.9× 114 4.6k
Felice Giuliante Italy 36 2.2k 0.9× 2.1k 1.1× 2.0k 1.7× 645 0.6× 1.2k 1.3× 197 4.1k
Sherrie Bhoori Italy 25 2.6k 1.1× 1.2k 0.6× 694 0.6× 1.7k 1.6× 477 0.5× 58 3.8k
Shinji Togo Japan 37 1.7k 0.7× 2.0k 1.1× 1.7k 1.5× 831 0.8× 1.1k 1.2× 167 3.9k
Young Joo Lee South Korea 36 1.4k 0.6× 2.3k 1.2× 1.7k 1.5× 1.0k 1.0× 1.5k 1.7× 167 4.2k
See Ching Chan Hong Kong 36 3.3k 1.4× 2.3k 1.2× 656 0.6× 1.5k 1.5× 506 0.5× 128 4.1k
Anne Rullier France 30 876 0.4× 2.0k 1.0× 1.9k 1.7× 521 0.5× 479 0.5× 82 3.6k

Countries citing papers authored by Gi Hong Choi

Since Specialization
Citations

This map shows the geographic impact of Gi Hong Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gi Hong Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gi Hong Choi more than expected).

Fields of papers citing papers by Gi Hong Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gi Hong Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gi Hong Choi. The network helps show where Gi Hong Choi may publish in the future.

Co-authorship network of co-authors of Gi Hong Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Gi Hong Choi. A scholar is included among the top collaborators of Gi Hong Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gi Hong Choi. Gi Hong Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Dong-Hyun, Gi Hong Choi, Han Na Lee, et al.. (2025). Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis. Cell Reports Medicine. 6(4). 102047–102047. 3 indexed citations
2.
Choi, Gi Hong, et al.. (2025). Significant Improvement in Long-Term Survival after Liver Resection for Hepatocellular Carcinoma: Evolving Outcomes over 20 Years. Yonsei Medical Journal. 66(10). 637–637. 1 indexed citations
4.
Cheah, Yee Lee, Caroline J. Simon, Mohamed Akoad, et al.. (2024). The learning curve for robotic living donor right hepatectomy: Analysis of outcomes in 2 specialized centers. Liver Transplantation. 31(2). 190–200. 5 indexed citations
5.
6.
Yoo, Jeong Eun, Dai Hoon Han, Jin Sub Choi, et al.. (2021). Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation. Gut and Liver. 16(3). 443–455. 16 indexed citations
7.
Lee, Hee Seung, Seungmin Bang, Dai Hoon Han, et al.. (2021). Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma. Cancers. 13(8). 1828–1828. 10 indexed citations
8.
Chung, Taek, Hyungjin Rhee, Hyo Sup Shim, et al.. (2021). Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. Gut and Liver. 16(4). 613–624. 19 indexed citations
9.
Rho, Seoung Yoon, et al.. (2020). Robotic Liver Resection. 1(1). 15–15. 1 indexed citations
10.
Kim, Sung‐Won, Jaeseung Shin, Do Young Kim, et al.. (2019). Radiomics on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma. Clinical Cancer Research. 25(13). 3847–3855. 155 indexed citations
11.
Lee, Jae Geun, Juhan Lee, Seung Hwan Song, et al.. (2015). Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation. Medicine. 94(38). e1569–e1569. 2 indexed citations
12.
Cho, Min Soo, Sung Hoon Kim, Seung Woo Park, et al.. (2012). Surgical Outcomes and Predicting Factors of Curative Resection in Patients with Hilar Cholangiocarcinoma: 10-Year Single-Institution Experience. Journal of Gastrointestinal Surgery. 16(9). 1672–1679. 73 indexed citations
13.
Choi, Gi Hong. (2012). Strategies to reduce HCC recurrence after liver transplantation. 198–201.
14.
Kim, Sung Hoon, Yoon Dae Han, Jae Gil Lee, et al.. (2011). MELD-Based Indices as Predictors of Mortality in Chronic Liver Disease Patients Who Undergo Emergency Surgery with General Anesthesia. Journal of Gastrointestinal Surgery. 15(11). 2029–2035. 11 indexed citations
15.
Choi, Gi Hong, et al.. (2009). Hepatocellular carcinoma during pregnancy. 158–159.
16.
Choi, Gi Hong, et al.. (2009). Robust state estimation approach to target localization using range difference of arrival data. 2009 ICCAS-SICE. 1790–1794. 6 indexed citations
17.
Kang, Chang Moo, Woo Ick Yang, Gi Hong Choi, et al.. (2008). A Case of Spleen-Preserving Laparoscopic Distal Pancreatectomy and Concomitant Cholecystectomy in Male Patient with Solid Pseudopapillary Neoplasm of the Pancreas and Gallstone. Journal of Laparoendoscopic & Advanced Surgical Techniques. 18(2). 259–265. 7 indexed citations
18.
Choi, Gi Hong, et al.. (1991). 화농성 척수 경막외 농양의 치험례. 대한정형외과학회지. 26(5). 1585–1589. 1 indexed citations
19.
Choi, Gi Hong, et al.. (1981). 슬관절에 발생한 Charcot Joint 1례 보고. 대한정형외과학회지. 16(4). 969–972. 1 indexed citations
20.
Choi, Gi Hong, et al.. (1980). 수부 손상에 대한 임상적 고찰. 대한정형외과학회지. 15(3). 464–470. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026